Therapeutic potential of pyruvate therapy for mitochondrial diseases.
Tanaka
Masashi
M
Nishigaki
Yutaka
Y
Fuku
Noriyuki
N
Ibi
Tohru
T
Sahashi
Ko
K
Koga
Yasutoshi
Y
D000328:Adult; D000818:Animals; D002135:Calcium-Binding Proteins / Q000172:deficiency / Q000235:genetics; D004789:Enzyme Activation; D000431:Ethanol / Q000378:metabolism; D005260:Female; D006019:Glycolysis / Q000187:drug effects; D006801:Humans; D019344:Lactic Acid / Q000378:metabolism; D051379:Mice; D028361:Mitochondrial Diseases / Q000188:drug therapy*; D027361:Organic Anion Transporters / Q000172:deficiency / Q000235:genetics; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D000081382:Pyruvate Dehydrogenase Acetyl-Transferring Kinase; D019289:Pyruvic Acid / Q000378:metabolism / Q000627:therapeutic use*
D002135:Calcium-Binding Proteins; D027361:Organic Anion Transporters; D000081382:Pyruvate Dehydrogenase Acetyl-Transferring Kinase; C008822:citrin; D019344:Lactic Acid; D000431:Ethanol; D019289:Pyruvic Acid; D017346:Protein Serine-Threonine Kinases